HomeCompareIMFI vs JNJ

IMFI vs JNJ: Dividend Comparison 2026

IMFI yields 8.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMFI wins by $13.9K in total portfolio value
10 years
IMFI
IMFI
● Live price
8.00%
Share price
$25.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.0K
Annual income
$1,327.68
Full IMFI calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IMFI vs JNJ

📍 IMFI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMFIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMFI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMFI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMFI
Annual income on $10K today (after 15% tax)
$680.14/yr
After 10yr DRIP, annual income (after tax)
$1,128.53/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, IMFI beats the other by $424.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMFI + JNJ for your $10,000?

IMFI: 50%JNJ: 50%
100% JNJ50/50100% IMFI
Portfolio after 10yr
$27.0K
Annual income
$1,077.73/yr
Blended yield
3.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMFI
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMFI buys
0
JNJ buys
0
No recent congressional trades found for IMFI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMFIJNJ
Forward yield8.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.0K$20.0K
Annual income after 10y$1,327.68$827.78
Total dividends collected$10.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IMFI vs JNJ ($10,000, DRIP)

YearIMFI PortfolioIMFI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,500$800.16$10,676$355.77+$824.00IMFI
2$13,165$860.00$11,407$389.39+$1.8KIMFI
3$15,007$920.10$12,198$426.53+$2.8KIMFI
4$17,038$980.20$13,056$467.62+$4.0KIMFI
5$19,270$1,040.03$13,987$513.12+$5.3KIMFI
6$21,718$1,099.37$14,998$563.56+$6.7KIMFI
7$24,397$1,157.99$16,098$619.52+$8.3KIMFI
8$27,320$1,215.69$17,295$681.69+$10.0KIMFI
9$30,505$1,272.30$18,599$750.82+$11.9KIMFI
10$33,968$1,327.68$20,022$827.78+$13.9KIMFI

IMFI vs JNJ: Complete Analysis 2026

IMFIStock

The investment seeks to track the investment results (before fees and expenses) of the Invesco Multi-Factor Income Index (the "underlying index"). The fund generally will invest at least 80% of its total assets in securities that comprise the underlying index. The underlying index is an index of other indexes and is comprised of component securities of such indexes (each, a "sub-index"). The underlying index is rebalanced monthly, and the fund will generally rebalance in accordance with the underlying index. It is non-diversified.

Full IMFI Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IMFI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMFI vs SCHDIMFI vs JEPIIMFI vs OIMFI vs KOIMFI vs MAINIMFI vs ABBVIMFI vs MRKIMFI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.